Recombinant Human Anti-CD3 x Human Anti-SCLC1 Bispecific Antibody (scFv-CH3) (BSFC-H279)

Recombinant Anti-CD3 x Anti-SCLC1 Bispecific Antibody (scFv-CH3) contains two chains. The anti-CD3 scFv is fused to the Knob-CH3 domain via a hinge region and the same as the anti-SCLC1 scFv to the Hole-CH3 domain, or vice versa. The KIH CH3 domains can facilitate to form a heterodimer and this bivalent binding leads to improvement in avidity. This BsAb can retarget T cells to tumor cells. It is designed for the research of Small cell lung cancer therapy.

Datasheet INQUIRY

Specifications

Targets

CD3 & SCLC1

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Small cell lung cancer

Targets

Target 1

CD3

Gene ID

916

UniProt ID

P07766

Alternative Names

CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3

Target 2

SCLC1

Gene ID

7864

Alternative Names

SCCL; SCLC; SCLC1; small cell cancer of the lung

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD3 x Human Anti-SCLC1 Bispecific Antibody (scFv-CH3) (BSFC-H279). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-CD3 x Human Anti-SCLC1 Bispecific Antibody (scFv-CH3) (CAT#: BSFC-H279)

Specifications

Targets

Customer Reviews and Q&As